Please wait a minute...
 Home  About the Journal Editorial Board Aims & Scope Peer Review Policy Subscription Contact us
Early Edition  //  Current Issue  //  Open Special Issues  //  Archives  //  Most Read  //  Most Downloaded  //  Most Cited
Aging and disease    2020, Vol. 11 Issue (3) : 465-469     DOI: 10.14336/AD.2020.0422
Editorial |
Adipose Stem Cells (ASCs) and Stromal Vascular Fraction (SVF) as a Potential Therapy in Combating (COVID-19)-Disease
Pietro Gentile1,*, Aris Sterodimas2
1Department of Surgical Science, University of Rome Tor Vergata, Rome, Italy
2Department of Plastic and Reconstructive Surgery, Metropolitan General Hospital, Athens, Greece
Download: PDF(235 KB)   HTML
Export: BibTeX | EndNote | Reference Manager | ProCite | RefWorks    

A recent and interesting study reported improved respiratory activity after intravenous administration of mesenchymal stem cells (MSCs) into patients affected by coronavirus disease 2019 (COVID-19). These outcomes displayed that intravenous infiltration of MSCs is a safe and efficacy treatment for COVID-19 pneumonia, a severe acute respiratory illness caused by the coronavirus 2 (SARS-CoV-2). Only 7 patients were treated, but with extraordinary results, opening a new strategy in COVID-19 therapy. Currently, no specific therapies against SARS-CoV-2 are available. The MSCs therapy outcomes reported, are striking, as these cells inhibit the over-activation of the immune system, promoting endogenous repair, by improving the lung microenvironment after the SARS-CoV-2 infection. The MSCs could represent an effective, autologous and safe therapy, and therefore, sharing these published results, here is reported the potential use possibilities in COVID-19 of the most common MSCs represented by Adipose Stem Cells (ASCs).

Keywords coronavirus      mesenchymal stem cells      Covid-19      adipose derived stem cells      Adipocyte secreted exosomal microRNA     
Corresponding Authors: Gentile Pietro   
Just Accepted Date: 22 April 2020   Issue Date: 13 May 2020
E-mail this article
E-mail Alert
Articles by authors
Gentile Pietro
Sterodimas Aris
Cite this article:   
Gentile Pietro,Sterodimas Aris. Adipose Stem Cells (ASCs) and Stromal Vascular Fraction (SVF) as a Potential Therapy in Combating (COVID-19)-Disease[J]. Aging and disease, 2020, 11(3): 465-469.
URL:     OR
[1] Leng Z, Zhu R, Hou W, et al. (2020). Transplantation of ACE2-mesenchymal stem cells improves the outcome of patients with COVID-19 pneumonia. Aging Dis, 11:216-228.
[2] Munster VJ, Koopmans M, van Doremalen N, et al. (2020). A novel coronavirus emerging in China - key questions for impact assessment. N Engl J Med, in press.
[3] Sohrabi C, Alsafi Z, O'Neill N, et al. (2020). World Health Organization declares Global Emergency: A review of the 2019 Novel Coronavirus (COVID-19). Int J Surg, pii: S1743-9191(20)30197-7.
[4] Zhou P, Yang XL, Wang XG, et al. (2020). A pneumonia outbreak associated with a new coronavirus of probable bat origin. Nature, 579:270-273.
[5] Prockop DJ, Oh JY (2012). Mesenchymal stem/stromal cells (MSCs): role as guardians of inflammation. Mol Ther, 20:14-20.
[6] Prockop DJ (2017). The exciting prospects of new therapies with mesenchymal stromal cells. Cytotherapy, 19:1-8.
[7] Connick P, Kolappan M, Crawley C, et al. (2012). Autologous mesenchymal stem cells for the treatment of secondary progressive multiple sclerosis: an open-label phase 2a proof-of-concept study. Lancet Neurol, 11:150-156
[8] Wilson JG, Liu KD, Zhuo NJ, et al. (2015). Mesenchymal stem (stromal) cells for treatment of ARDS: a phase 1 clinical trial. Lancet Respir Med, 3:24-32.
[9] Gentile P, Piccinno MS, Calabrese C (2019). Characteristics and Potentiality of Human Adipose-Derived Stem Cells (hASCs) Obtained from Enzymatic Digestion of Fat Graft. Cells, 25:8(3).
[10] Sinjari B, Pizzicannella J, D'Aurora M, et al. (2019). Curcumin/Liposome Nanotechnology as Delivery Platform for Anti-inflammatory Activities via NFkB/ERK/pERK Pathway in Human Dental Pulp Treated With 2-HydroxyEthyl MethAcrylate (HEMA). Front Physiol, 10:633.
[11] Trubiani O, Pizzicannella J, Caputi S, et al. (2019). Periodontal Ligament Stem Cells: Current Knowledge and Future Perspectives. Stem Cells Dev, 28:995-1003.
[12] Trubiani O, Marconi GD, Pierdomenico SD, et al. (2019). Human Oral Stem Cells, Biomaterials and Extracellular Vesicles: A Promising Tool in Bone Tissue Repair. Int J Mol Sci, 20(20). pii: E4987.
[13] Casteilla L, Planat-Bénard V, Cousin B, et al. (2005). Plasticity of adipose tissue: A promising therapeutic avenue in the treatment of cardiovascular and blood diseases? Arch. Mal. Coeur Vaiss, 98:922-926.
[14] Oedayrajsingh-Varma, MJ, van Ham SM, Knippenberg M, et al. (2006). Adipose tissue-derived mesenchymal stem cell yield and growth characteristics are affected by the tissue-harvesting procedure. Cytotherapy, 8:166-177.
[15] Gentile P, Orlandi A, Scioli MG, et al. (2012). A comparative translational study: the combined use of enhanced stromal vascular fraction and platelet-rich plasma improves fat grafting maintenance in breast reconstruction. Stem Cells Transl Med, 1:341-351.
[16] Gentile P, Scioli MG, Orlandi A, et al. (2015). Breast Reconstruction with Enhanced Stromal Vascular Fraction Fat Grafting: What Is the Best Method? Plast Reconstr Surg Glob Open, 8:e406.
[17] Gentile P, Casella D, Palma E, et al. (2019). Engineered Fat Graft Enhanced with Adipose-Derived Stromal Vascular Fraction Cells for Regenerative Medicine: Clinical, Histological and Instrumental Evaluation in Breast Reconstruction. J Clin Med, 12:8.
[18] Gentile P, Garcovich S (2019). Concise Review: Adipose-Derived Stem Cells (ASCs) and Adipocyte-Secreted Exosomal microRNA (A-SE-miR) Modulate Cancer Growth and promote Wound Repair. J Clin Med, 15:8.
[19] Delort L, Rossary A, Farges MC, et al. (2015). Leptin, adipocytes and breast cancer: Focus on inflammation and anti-tumor immunity. Life Sci. 2015, 1:37-48.
[20] Gentile P, De Angelis B, Pasin M, et al (2014). Adipose-derived stromal vascular fraction cells and platelet-rich plasma: basic and clinical evaluation for cell-based therapies in patients with scars on the face. J Craniofac Surg, 25:267-72.
[21] Gentile P, Calabrese C, De Angelis B, et al. (2019). Impact of the Different Preparation Methods to Obtain Human Adipose-Derived Stromal Vascular Fraction Cells (AD-SVFs) and Human Adipose-Derived Mesenchymal Stem Cells (AD-MSCs): Enzymatic Digestion Versus Mechanical Centrifugation. Int J Mol Sci, 2:20.
[22] Bieback K Kern S; Kocaömer A,et al. (2008). Comparing mesenchymal stromal cells from different human tissues: Bone marrow, adipose tissue and umbilical cord blood. BioMed Mater Eng, 18:S71-S76.
[23] Dicker A, Le Blanc K, Aström G, et al. (2005). Functional studies of mesenchymal stem cells derived from adult human adipose tissue. Exp. Cell Res, 308:283-290.
[24] Hashmi S, Ahmed M, Murad MH, et al. (2016). Survival after mesenchymal stromal cell therapy in steroid-refractory acute graft-versus-host disease: systematic review and meta-analysis. Lancet Haematol, 3:E45-E52.
[25] Kamen DL, Nietert PJ, Wang H, et al. (2018), CT-04 Safety and efficacy of allogeneic umbilical cord-derived mesenchymal stem cells (MSCs) in patients with systemic lupus erythematosus: results of an open-label phase I study. Lupus Sci Med, 5:A46-A47.
[26] Cervelli V, Gentile P, De Angelis B, et al (2011). Application of enhanced stromal vascular fraction and fat grafting mixed with PRP in post-traumatic lower extremity ulcers. Stem Cell Res, 6:103-11.
[27] Lendeckel S, Jödicke A, Christophis P, et al. (2004). Autologous stem cells (adipose) and fibrin glue used to treat widespread traumatic calvarial defects: case report. J Cranio-Maxillofacial Surg, 32:370-373.
[28] Tanikawa DYS, Aguena M, Bueno DF, et al. (2013). Fat graft supplemented with adipose-derived stromal cells in the rehabilitation of patients with craniofacial microsomia. Plast Reconstr Surg, 132:141-152.
[29] Rigotti G, Marchi A, Galie M, et al. (2007). Clinical treatment of radiotherapy tissue damage by lipoaspirate transplant: a healing process mediated by adipose-derived adult stem cells. Plast Reconstr Surg, 119:1409-22.
[30] P´erez-Cano R, Vranckx JJ, Lasso JM, et al. (2012). Prospective trial of adipose-derived regenerative cell (ADRC)-enriched fat grafting for partial mastectomy defects: the RESTORE-2 trial. Eur J Surg Oncol, 38:382-389.
[31] Fauci AS, Lane HC, Redfield RR (2020). Covid-19 - Navigating the uncharted. N Engl J Med, in press.
[1] Hong Liu, Shiyan Chen, Min Liu, Hao Nie, Hongyun Lu. Comorbid Chronic Diseases are Strongly Correlated with Disease Severity among COVID-19 Patients: A Systematic Review and Meta-Analysis[J]. Aging and disease, 2020, 11(3): 668-678.
[2] Fulzele Sadanand, Sahay Bikash, Yusufu Ibrahim, Lee Tae Jin, Sharma Ashok, Kolhe Ravindra, Isales Carlos M. COVID-19 Virulence in Aged Patients Might Be Impacted by the Host Cellular MicroRNAs Abundance/Profile[J]. Aging and disease, 2020, 11(3): 509-522.
[3] Öztürk Selçuk, Elçin Ayşe Eser, Elçin Yaşar Murat. Mesenchymal Stem Cells for Coronavirus (COVID-19)-Induced Pneumonia: Revisiting the Paracrine Hypothesis with New Hopes?[J]. Aging and disease, 2020, 11(3): 477-479.
[4] Chakrabarti Sankha Shubhra, Kaur Upinder, Banerjee Anindita, Ganguly Upasana, Banerjee Tuhina, Saha Sarama, Parashar Gaurav, Prasad Suvarna, Chakrabarti Suddhachitta, Mittal Amit, Agrawal Bimal Kumar, Rawal Ravindra Kumar, Zhao Robert Chunhua, Gambhir Indrajeet Singh, Khanna Rahul, Shetty Ashok K, Jin Kunlin, Chakrabarti Sasanka. COVID-19 in India: Are Biological and Environmental Factors Helping to Stem the Incidence and Severity?[J]. Aging and disease, 2020, 11(3): 480-488.
[5] Xiaotian Dong, Mengyan Wang, Shuangchun Liu, Jiaqi Zhu, Yanping Xu, Hongcui Cao, Lanjuan Li. Immune Characteristics of Patients with Coronavirus Disease 2019 (COVID-19)[J]. Aging and disease, 2020, 11(3): 642-648.
[6] Zikuan Leng, Rongjia Zhu, Wei Hou, Yingmei Feng, Yanlei Yang, Qin Han, Guangliang Shan, Fanyan Meng, Dongshu Du, Shihua Wang, Junfen Fan, Wenjing Wang, Luchan Deng, Hongbo Shi, Hongjun Li, Zhongjie Hu, Fengchun Zhang, Jinming Gao, Hongjian Liu, Xiaoxia Li, Yangyang Zhao, Kan Yin, Xijing He, Zhengchao Gao, Yibin Wang, Bo Yang, Ronghua Jin, Ilia Stambler, Lee Wei Lim, Huanxing Su, Alexey Moskalev, Antonio Cano, Sasanka Chakrabarti, Kyung-Jin Min, Georgina Ellison-Hughes, Calogero Caruso, Kunlin Jin, Robert Chunhua Zhao. Transplantation of ACE2- Mesenchymal Stem Cells Improves the Outcome of Patients with COVID-19 Pneumonia[J]. Aging and disease, 2020, 11(2): 216-228.
[7] Shijin Xia, Changxi Zhou, Bill Kalionis, Xiaoping Shuang, Haiyan Ge, Wen Gao. Combined Antioxidant, Anti-inflammaging and Mesenchymal Stem Cell Treatment: A Possible Therapeutic Direction in Elderly Patients with Chronic Obstructive Pulmonary Disease[J]. Aging and disease, 2020, 11(1): 129-140.
[8] Linsha Ma, Jingchao Hu, Yu Cao, Yilin Xie, Hua Wang, Zhipeng Fan, Chunmei Zhang, Jinsong Wang, Chu-Tse Wu, Songlin Wang. Maintained Properties of Aged Dental Pulp Stem Cells for Superior Periodontal Tissue Regeneration[J]. Aging and disease, 2019, 10(4): 793-806.
[9] Yoorim Choi, Dong Suk Yoon, Kyoung-Mi Lee, Seong Mi Choi, Myon-Hee Lee, Kwang Hwan Park, Seung Hwan Han, Jin Woo Lee. Enhancement of Mesenchymal Stem Cell-Driven Bone Regeneration by Resveratrol-Mediated SOX2 Regulation[J]. Aging and disease, 2019, 10(4): 818-833.
[10] Hongling Li, Junfen Fan, Linyuan Fan, Tangping Li, Yanlei Yang, Haoying Xu, Luchan Deng, Jing Li, Tao Li, Xisheng Weng, Shihua Wang, Robert Chunhua Zhao. MiRNA-10b Reciprocally Stimulates Osteogenesis and Inhibits Adipogenesis Partly through the TGF-β/SMAD2 Signaling Pathway[J]. Aging and disease, 2018, 9(6): 1058-1073.
[11] Yan Liang, Gao Rui, Liu Yang, He Baorong, Lv Shemin, Hao Dingjun. The Pathogenesis of Ossification of the Posterior Longitudinal Ligament[J]. Aging and disease, 2017, 8(5): 570-582.
[12] Long Qianfa, Luo Qiang, Wang Kai, Bates Adrian, Shetty Ashok K.. Mash1-dependent Notch Signaling Pathway Regulates GABAergic Neuron-Like Differentiation from Bone Marrow-Derived Mesenchymal Stem Cells[J]. Aging and disease, 2017, 8(3): 301-313.
[13] Li Jiao, Liu Xingyu, zuo Bin, Zhang Li. The Role of Bone Marrow Microenvironment in Governing the Balance between Osteoblastogenesis and Adipogenesis[J]. Aging and disease, 2016, 7(4): 514-525.
Full text



Copyright © 2014 Aging and Disease, All Rights Reserved.
Address: Aging and Disease Editorial Office 3400 Camp Bowie Boulevard Fort Worth, TX76106 USA
Fax: (817) 735-0408 E-mail:
Powered by Beijing Magtech Co. Ltd